NASDAQ: AURAAura Biosciences Inc Stock Ownership - Who owns Aura Biosciences?
Insider buying vs selling
Have Aura Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Julie B. Feder | Chief Financial Officer | 2024-01-23 | 6,609 | $7.64 | $50.52kSell |
| Los Pinos Elisabet De | President and Chief Executive Officer | 2024-01-23 | 15,853 | $7.64 | $121.13kSell |
| Matrix Capital Management Company LP | 10% Owner | 2023-11-09 | 1,560,000 | $9.00 | $14.04MBuy |
| David Michael Johnson | Director | 2023-11-08 | 10,000 | $7.30 | $73.00kBuy |
| David Michael Johnson | Director | 2023-11-08 | 10,000 | $7.30 | $73.00kBuy |
| David Michael Johnson | Director | 2023-11-08 | 9,601 | $7.30 | $70.09kBuy |
| David Michael Johnson | Director | 2023-11-07 | 76,000 | $7.17 | $544.92kBuy |
| David Michael Johnson | Director | 2023-11-07 | 47,000 | $7.17 | $336.99kBuy |
| David Michael Johnson | Director | 2023-11-07 | 47,000 | $7.17 | $336.99kBuy |
| Los Pinos Elisabet De | President and Chief Executive Officer | 2023-11-06 | 7,449 | $12.03 | $89.61kSell |
AURA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AURA insiders and whales buy or sell their stock.
AURA Shareholders
What type of owners hold Aura Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Matrix Capital Management Company LP | 13.98% | 6,922,870 | $49.15M | Insider |
| Matrix Capital Management Company LP | 13.98% | 6,922,870 | $49.15M | Institution |
| Eventide Asset Management LLC | 11.72% | 5,802,682 | $41.20M | Institution |
| Adage Capital Partners GP LLC | 8.53% | 4,225,000 | $30.00M | Institution |
| Citadel Advisors LLC | 7.34% | 3,631,294 | $25.78M | Institution |
| Medicxi Ventures Management Jersey Ltd | 6.14% | 3,039,892 | $21.58M | Institution |
| Blackrock Inc | 4.24% | 2,098,745 | $14.90M | Institution |
| Vanguard Group Inc | 3.50% | 1,730,431 | $12.29M | Institution |
| Nantahala Capital Management LLC | 2.67% | 1,321,860 | $9.39M | Institution |
| Goldman Sachs Group Inc | 2.10% | 1,037,299 | $7.36M | Institution |
AURA vs Biotech Stocks
Aura Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.